The study will focus on measures of obesity (including body fat %), metabolism (HbA1c), and sleep. The teams will leverage Mayo Clinics medical expertise and Viomes proprietary microbiome analysis platform.

Together, Viome believes they will enable a better understanding of how nutrition affects chronic diseases, and explore the effectiveness of personalized nutrition as a strategy to help in treatment, and possibly even prevention, of these diseases.

"Everything we do at Viome is in an effort to create a world wher illness is optional. This partnership is no exception," said Naveen Jain, CEO and founder of Viome. "Through this collaboration with Mayo Clinic, an iconic organization committed to providing the best patient care, we will be able to amplify the critical importance of personalized nutrition and its direct impact on people suffering from obesity and sleep disorders."

This initiative will help leverage Mayo Clinics research resources with Viomes AI technology and insights into the gut microbiome The study will be led by Virend Somers, M.D., Ph.D., director of the Cardiovascular Facility and the Sleep Facility within Mayo Clinics Center for Clinical and Translational Science.

By exploring the role of nutrition in chronic diseases, the collaboration will open up the possibility of developing personalized strategies and interventions to help in their management.